SU453842A3 - - Google Patents
Info
- Publication number
- SU453842A3 SU453842A3 SU1761120A SU1761120A SU453842A3 SU 453842 A3 SU453842 A3 SU 453842A3 SU 1761120 A SU1761120 A SU 1761120A SU 1761120 A SU1761120 A SU 1761120A SU 453842 A3 SU453842 A3 SU 453842A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- compound
- general formula
- group
- solution
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
(54) СПОСОБ ПОЛУЧЕНИЯ ОПТИЧЕСКИ АКТИВНЫХ 1,4-БЕНЗОДИАЗЕПИНОВ N-C ..s-R, /V HN H где Ri-RS и A имеют указанные значени . Путем отщеплени защитной групны А от соединений IV получаетс свободна аминогруппа , реагирующа затем с карбонилгруппой , причем образуютс соединени общей формулы I. Согласно изобретению реакцию соединений II н III нровод т в инертном растворителе и отщепление защитной группы А от соединений общей формулы IV путем гидролиза в щелочной или кислой среде. Пример 1. 2,32 г (10 моль) 2-амино-5хлорбензофеноиа и 1,89 г (10 моль) BOC-Lаланииа раствор ют в 50 мл CHgClg и к полученному лед ному раствору прибавл ют при перемещивании 2,26 г (11 ммоль) DCCD (днциклокарбодиимид ). Через 30 мин удал ют холодильник и раствор перемешивают в течение суток при комнатной температуре. Раствор сохран ет желтый цвет отчасти непрореагировавшего амина. Выделившуюс дициклогексилмочевину отсасывают и фильтрат упаривают до объема приблизительно 3-4 мл. Концентрированный раствор подвергают хроматографии на колонке (220 г силикагел , хлороформ - этилацетат 95:5) и из фракций 16-28 (по 50 мл) получают 69% сырого продукта формулы V Х. вают в течение получаса до 35-40С. Высушенные экстракты (CaCl2, Na2S04) упаривают и получают 90% сырого ( + )-7-хлор-1,3-дигидро-3-метил-5-фепил-2Н - 1,4-бензодиазепин-2оиа (3 S), очищенного перекристаллизацией из простого эфира. Точки плавлени : 163-165°С ЯМР(вСНС1з), И5,8 171,5, 201, .„в + 332,5, , . + 444, + 338° (С 1,56 в СНС1з). Пример 2. Н О ,ХНгс ) 0/v HN Н Соедииение VI приведенной формулы получают так же, как соедииение V, причем примен ют 2,65 г (10 ммоль) BOC-L-фенилаланина . Выдел ют сырой продукт после удалени дициклогексилмочевины путем упаривани растворител в вакууме и последовательной кристаллизации остатка, начина с 50 мл эфирного раствора. Получают 2,8 г (58,5%) сырого соединени VI, т. пл. 135-139°С. После перекристаллизации из диоксана - петролейиого эфира (два раза) точка плавлени повышаетс до 14ГС. 1,5 г соединени VI циклизируют согласно описанному в примере 1 способу. При этом получают 0,6 г сырого ( + )-7-хлор-1,3-дигидро3 - беизил-5-фенил - 1,4 - бензодиазеиин - 2-она (3S). П р и м е р 3. Аналогично примерам 1 и 2 получают при применении 1,5 г ВОС-тирозина соединени VII и VIII, формулы которых приведены ниже.(54) METHOD FOR OBTAINING OPTICALLY ACTIVE 1,4-BENZODIAZEPINES N-C. S-R, / V HN H where Ri-RS and A have the indicated values. By cleaving the protective group A from compounds IV, a free amino group is obtained, which then reacts with the carbonyl group, and compounds of general formula I are formed. According to the invention, the reaction of compounds II and III is carried out in an inert solvent and the removal of protective group A from compounds of general formula IV or acidic environment. Example 1. 2.32 g (10 mol) of 2-amino-5-chlorobenzophenoia and 1.89 g (10 mol) of BOC-L alkania are dissolved in 50 ml of CHgClg and 2.26 g (11 mmol) DCCD (dicyclocarbodiimide). After 30 minutes, the refrigerator was removed and the solution was stirred at room temperature overnight. The solution retains the yellow color of a partly unreacted amine. The released dicyclohexyl urea is sucked off and the filtrate is evaporated to a volume of approximately 3-4 ml. The concentrated solution is subjected to chromatography on a column (220 g of silica gel, chloroform - ethyl acetate 95: 5) and 69% of the crude product of the formula V X is obtained from fractions 16-28 (50 ml each) in half an hour to 35-40 ° C. Dried extracts (CaCl2, Na2S04) are evaporated and 90% of crude (+) -7-chloro-1,3-dihydro-3-methyl-5-phenyl-2H - 1,4-benzodiazepin-2oia (3 S) purified by recrystallization from ether. Melting points: 163-165 ° C NMR (vSSN1z), I5.8 171.5, 201. In + 332.5,. + 444, + 338 ° (С 1.56 in СНС1з). EXAMPLE 2 H O, HNGs) 0 / v HN H Compound VI of the above formula is prepared in the same way as Compound V, and 2.65 g (10 mmol) of BOC-L-phenylalanine is used. The crude product is isolated after removing the dicyclohexyl urea by evaporation of the solvent in vacuo and successive crystallization of the residue, starting with 50 ml of ethereal solution. 2.8 g (58.5%) of crude compound VI are obtained, m.p. 135-139 ° C. After recrystallization from dioxane-petroleum ether (twice), the melting point rises to 14 ° C. 1.5 g of compound VI is cyclized as described in Example 1. At the same time, 0.6 g of crude (+) -7-chloro-1,3-dihydro3-beisyl-5-phenyl-1,4-benzodiaziein-2-one (3S) is obtained. EXAMPLE 3 Analogously to Examples 1 and 2, when using 1.5 g of BOC-tyrosine, Compounds VII and VIII are obtained, the formulas of which are given below.
с т. пл. 148-153°С. После многократной перекристаллизации из циклогексана продукт плавитс при 153-155°С. ИК-иолосы (в КВг) отчетливо выражены при 3310, 1710 (плечо), 1678, 1648, 1575, 1520, 1490, 1285, 1250, 1160, 955 см-1.with t. pl. 148-153 ° C. After repeated recrystallization from cyclohexane, the product melts at 153-155 ° C. IR-hairs (in KBG) are clearly expressed at 3310, 1710 (shoulder), 1678, 1648, 1575, 1520, 1490, 1285, 1250, 1160, 955 cm-1.
Вычислено, %; С 62,61; Н 5,75; N 6,95.Calculated,%; C, 62.61; H 5.75; N 6.95.
C2lH23N2O4Cl.C2lH23N2O4Cl.
Найдено, %: С 62,48; Н 5,11; N 6,72.Found,%: C 62.48; H 5.11; N 6.72.
885 мг соединени V раствор ют при перемещиваиии в 4 мл лед ной уксусной кислоты. К раствору добавл ют при интенсивном перемешивании 5 мл концеитрировапной НС1 и продолжают перемешивать в течение 10 мин, чтобы удалить пузырьки из раствора. Реакционную смесь прибавл ют по капл м к 100мл 10%-ного водного раствора Ма2СОз и нагре I II885 mg of Compound V is dissolved by transferring to 4 ml of glacial acetic acid. Under vigorous stirring, 5 ml of conicity with HCl is added to the solution and stirred for 10 minutes to remove the bubbles from the solution. The reaction mixture is added dropwise to 100 ml of a 10% aqueous solution of Ma2CO3 and heat I II
. ...СИ, . ... SI,
С1C1
Предмет изобретени Subject invention
1. Способ получени оптически активных 1,4-бензодиазепинов общей формулы1. A method for producing optically active 1,4-benzodiazepines of the general formula
66
где RI и Rz имеют указанные значени , подвергают взаимодействию с соединением общей формулыwhere RI and Rz have the indicated meanings, are reacted with a compound of the general formula
,,
содержащих в положении 3 асимметрический атом углерода,containing in position 3 asymmetric carbon atom,
где RI - водород, галоген или нитрогрунпа, R2 - водород или низший алкил, содержащий до четырех атомов углерода ,where RI is hydrogen, halogen or nitrocorn, R2 is hydrogen or lower alkyl containing up to four carbon atoms,
Кз - нормальный или изо-низший алкил ,Cs - normal or iso-lower alkyl,
содержащий до трех атомов углерода, замещенный низщий алкил, бензил, п-оксибензил или триптофанилостаток, отличающийс тем, что соединение общей формулыcontaining up to three carbon atoms, substituted lower alkyl, benzyl, p-hydroxybenzyl or tryptophanil residue, characterized in that the compound of the general formula
....
НООСх хВьNoos xB
СWITH
HN йHn th
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH386871A CH554349A (en) | 1971-03-17 | 1971-03-17 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 1,3-DIHYDRO-2H-1,4-BENZODIAZEPINE-2-ONES. |
Publications (1)
Publication Number | Publication Date |
---|---|
SU453842A3 true SU453842A3 (en) | 1974-12-15 |
Family
ID=4265209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU1761120A SU453842A3 (en) | 1971-03-17 | 1972-03-17 |
Country Status (16)
Country | Link |
---|---|
AT (1) | AT327909B (en) |
BE (1) | BE780892A (en) |
CA (1) | CA992079A (en) |
CH (1) | CH554349A (en) |
DE (1) | DE2212526A1 (en) |
ES (1) | ES400851A1 (en) |
FR (1) | FR2130342B1 (en) |
GB (2) | GB1391081A (en) |
HU (1) | HU165496B (en) |
IL (2) | IL38991A (en) |
NL (1) | NL7203536A (en) |
NO (1) | NO137896C (en) |
SE (1) | SE399887B (en) |
SU (1) | SU453842A3 (en) |
YU (1) | YU34882B (en) |
ZA (1) | ZA721845B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH602672A5 (en) * | 1974-06-28 | 1978-07-31 | Hoffmann La Roche | |
CH603655A5 (en) * | 1974-10-21 | 1978-08-31 | Hoffmann La Roche | |
EP1210338A2 (en) * | 1999-08-05 | 2002-06-05 | IGT Pharma Inc. | 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system |
-
1971
- 1971-03-17 CH CH386871A patent/CH554349A/en not_active IP Right Cessation
-
1972
- 1972-03-14 AT AT214972A patent/AT327909B/en not_active IP Right Cessation
- 1972-03-15 DE DE19722212526 patent/DE2212526A1/en active Pending
- 1972-03-16 YU YU697/72A patent/YU34882B/en unknown
- 1972-03-16 ES ES72400851A patent/ES400851A1/en not_active Expired
- 1972-03-16 NL NL7203536A patent/NL7203536A/xx unknown
- 1972-03-16 NO NO853/72A patent/NO137896C/en unknown
- 1972-03-16 IL IL38991A patent/IL38991A/en unknown
- 1972-03-16 CA CA137,294A patent/CA992079A/en not_active Expired
- 1972-03-16 IL IL47123A patent/IL47123A/en unknown
- 1972-03-16 FR FR7209250A patent/FR2130342B1/fr not_active Expired
- 1972-03-17 SU SU1761120A patent/SU453842A3/ru active
- 1972-03-17 GB GB1256772A patent/GB1391081A/en not_active Expired
- 1972-03-17 BE BE780892A patent/BE780892A/en unknown
- 1972-03-17 ZA ZA721845A patent/ZA721845B/en unknown
- 1972-03-17 GB GB4955674A patent/GB1391082A/en not_active Expired
- 1972-03-17 HU HUCA323A patent/HU165496B/hu unknown
- 1972-03-17 SE SE7203457A patent/SE399887B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA721845B (en) | 1972-12-27 |
YU34882B (en) | 1980-04-30 |
IL38991A (en) | 1976-09-30 |
HU165496B (en) | 1974-09-28 |
FR2130342B1 (en) | 1977-01-14 |
GB1391082A (en) | 1975-04-16 |
IL47123A (en) | 1976-09-30 |
NO137896B (en) | 1978-02-06 |
ES400851A1 (en) | 1975-01-16 |
FR2130342A1 (en) | 1972-11-03 |
ATA214972A (en) | 1975-05-15 |
BE780892A (en) | 1972-07-17 |
IL38991A0 (en) | 1972-05-30 |
CA992079A (en) | 1976-06-29 |
CH554349A (en) | 1974-09-30 |
DE2212526A1 (en) | 1972-09-21 |
AT327909B (en) | 1976-02-25 |
SE399887B (en) | 1978-03-06 |
NL7203536A (en) | 1972-09-19 |
NO137896C (en) | 1978-05-16 |
YU69772A (en) | 1979-10-31 |
GB1391081A (en) | 1975-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU691089A3 (en) | Method of producing carbonyl-substituted 1-sulphonylbenzimidazoles | |
HU195182B (en) | Process for production of /z/-1-phenil-1-diethil-amino-carbonil-2-amino-methil-cyclopropan hcl | |
SU508199A3 (en) | Method for producing morpholine derivatives | |
JP3973941B2 (en) | Method for producing δ-aminopentadienoic acid ester derivative | |
SU453842A3 (en) | ||
HU205116B (en) | Process for producing 1,4-diazabicyclo/3.2.2./nonane | |
EP0092194B1 (en) | Method of obtaining optically active half esters | |
NO883080L (en) | PROCEDURE FOR THE MANUFACTURE OF NEW CEFEM COMPOUNDS. | |
US4049659A (en) | Process for the preparation of 4-oxo-hexahydro-pyrazinoisoquinoline derivatives | |
EP0078804A1 (en) | Method of preparation of delta2 n-heterocycles | |
EP0040332B1 (en) | Antihypertensive lactams | |
EP0839800B1 (en) | Process for preparing halogenoacetamide derivatives | |
US4443621A (en) | p-Nitrophenyl 3-bromo-2,2-diethoxy-propionate and synthetic utility therefor | |
US4918190A (en) | Crystalline complex compounds of propargyl alcohols and tertiary diamines, and process of separation and purification of propargyl alcohols using the same | |
US4564677A (en) | Preparation of N-amino compounds | |
CA1202625A (en) | Process for the preparation of 5, 11-dihydro-11-[(4- methyl-1-piperazinyl)acetyl]-6h-pyrido[2,3-b] [1,4] benzodiazepin-6-ones | |
US5290947A (en) | Process for the preparation of pyrrole derivates | |
US4075219A (en) | Epimerization process | |
FI69838C (en) | REFERENCE TO A FRAMSTAELLNING AV 1,2,3-THIADIAZOLE-5-YLURINAEMNEN | |
SU461510A3 (en) | Method for preparing alkylsulfonic acid esters of 1,3,2-oxazaphosphacyclic compounds | |
US4355166A (en) | Quinuclidinic ester and derivatives of phenoxycarboxylic acids | |
US5338868A (en) | Process for preparing alpha-amino-phenylacetic acid-trifluoromethane sulfonic acid mixed anhydrides | |
AT397385B (en) | METHOD FOR PRODUCING CHINOLINE CARBONIC ACID DERIVATIVES | |
US4432901A (en) | Beta-lactam compounds containing a C-acetal group and process for their preparation | |
SU561513A3 (en) | The method of obtaining piperazine derivatives or their salts |